Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report UIT achieves up to 95% residual stress elimination in welded joints without post-weld heat treatment. Compare UIT vs VSR with validated parameters and selection guidance.
Article | Report How to reduce heat accumulation in confined electronics without active cooling — PCMs, vapor chambers, radiative coatings, and moisture sorption strategies reviewed.
Article | Report Discover 3 proven engineering approaches—gradient coatings, bio-inspired laminates, and multilayer systems—to boost impact resistance while keeping surface hardness intact.
Article | Report Five proven strategies for flexible thermal interface materials—from liquid metal composites to hybrid BN-CNT networks—achieving 5–10 W/m·K with 400% elongation.
Article | Report Casgevy vs Lyfgenia: compare CRISPR/Cas9 BCL11A editing against lentiviral gene addition for sickle cell disease — mechanisms, delivery, efficacy, and safety data.
Article | Report How does lecanemab's protofibril-selective mechanism differ from aducanumab? Explore binding profiles, ARIA rates, and clinical trial outcomes in this in-depth analysis.
Article | Report Dual and triple agonists, amylin combinations, NK2R agonists and more: discover the new drug mechanisms competing with GLP-1 agonists for obesity treatment.
Article | Report CATL's technology roadmap from 2011 to 2026: how the world's largest EV battery maker evolved from NCM to LFP, sodium-ion, and Qilin CTP 3.0 — with competitive analysis.
Article | Report Five proven strategies to improve tensile strength without adding weight in aerospace — from Al-Li alloys to β-titanium and topology optimisation. Data-backed analysis.
Article | Report Discover leading materials informatics platforms enabling AI-driven inverse design, featuring ELN/LIMS integration. Find the best tools for your materials R&D.
Updated on March 20,2026|Written by Patsnap Team The FDA operates five distinct expedited programs for drugs and biologics addressing serious …
Updated on March 20,2026|Written by Patsnap Team Achondroplasia is the most common form of genetic short-limb dwarfism, affecting approximately 1 …
Continue reading "What Is Achondroplasia? Genetics, Clinical Features, and Emerging Treatments"
Updated on March 20,2026|Written by Patsnap Team Bruton’s tyrosine kinase (BTK) is one of the most clinically validated drug targets …
Continue reading "What Is BTK? Target Biology, Inhibitor Classes, and Clinical Applications"
Updated on March 20, 2026 | Written by PatSnap Team Twelve drugs received Breakthrough Therapy designation (BTD) in February 2026 …
Continue reading "Breakthrough Therapy Designations: February 2026 Analysis"
Updated on March 20,2026|Written by Patsnap Team In February 2026, 82 drugs received expedited review designations across the US, EU, …
Continue reading "Expedited Review Pathways: 82 Drugs Designated in February 2026"